메뉴 건너뛰기




Volumn 9, Issue 6, 2011, Pages 711-720

Myths and truths of growth hormone and testosterone therapy in heart failure

Author keywords

growth hormone; heart failure; insulin like growth factor; testosterone

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; OXYMETHOLONE; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

EID: 79959920356     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.11.25     Document Type: Review
Times cited : (10)

References (93)
  • 1
    • 28744446343 scopus 로고    scopus 로고
    • ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the american college of cardiology/american heart association task force on practice guidelines writing committee to update the 2001 guidelines for the evaluation and management of heart failure
    • Hunt SA, Abraham WT, Chin MH et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112(12), e154-e235 (2005)
    • (2005) Circulation , vol.112 , Issue.12
    • Hunt, S.A.1    Abraham, W.T.2    Chin, M.H.3
  • 2
    • 17944374924 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and treatment of chronic heart failure
    • DOI 10.1053/euhj.2001.2783
    • Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur. Heart J. 22(17), 1527-1560 (2001) (Pubitemid 32801300)
    • (2001) European Heart Journal , vol.22 , Issue.17 , pp. 1527-1560
    • Remme, W.J.1    Swedberg, K.2
  • 5
    • 69949113078 scopus 로고    scopus 로고
    • Heart failure as a multiple hormonal deficiency syndrome
    • Sacca L. Heart failure as a multiple hormonal deficiency syndrome. Circ. Heart Fail. 2(2), 151-156 (2009)
    • (2009) Circ. Heart Fail. , vol.2 , Issue.2 , pp. 151-156
    • Sacca, L.1
  • 7
    • 0026702877 scopus 로고
    • Physiology of growth hormone secretion and action
    • Casanueva FF. Physiology of growth hormone secretion and action. Endocrinol. Metab. Clin. North Am. 21(3), 483-517 (1992)
    • (1992) Endocrinol. Metab. Clin. North Am. , vol.21 , Issue.3 , pp. 483-517
    • Casanueva, F.F.1
  • 8
    • 49649106996 scopus 로고    scopus 로고
    • The GH-IGF-I axis and the cardiovascular system: Clinical implications
    • Oxf.
    • Colao A. The GH-IGF-I axis and the cardiovascular system: clinical implications. Clin. Endocrinol. (Oxf.) 69(3), 347-358 (2008)
    • (2008) Clin. Endocrinol. , vol.69 , Issue.3 , pp. 347-358
    • Colao, A.1
  • 9
    • 0034803527 scopus 로고    scopus 로고
    • Insulin-like growth factor 1 (IGF-1): A growth hormone
    • DOI 10.1136/mp.54.5.311
    • Laron Z. Insulin-like growth factor 1 (IGF-1): a growth hormone. Mol. Pathol. 54(5), 311-316 (2001) (Pubitemid 32928257)
    • (2001) Journal of Clinical Pathology - Molecular Pathology , vol.54 , Issue.5 , pp. 311-316
    • Laron, Z.1
  • 11
    • 0027970820 scopus 로고
    • Growth hormone and the heart
    • DOI 10.1210/er.15.5.555
    • Sacca L, Cittadini A, Fazio S. Growth hormone and the heart. Endocr. Rev. 15(5), 555-573 (1994) (Pubitemid 24328207)
    • (1994) Endocrine Reviews , vol.15 , Issue.5 , pp. 555-573
    • Sacca, L.1    Cittadini, A.2    Fazio, S.3
  • 13
    • 0027976585 scopus 로고
    • Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells
    • Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC, Goligorsky MS. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int. 45(2), 598-604 (1994) (Pubitemid 24065099)
    • (1994) Kidney International , vol.45 , Issue.2 , pp. 598-604
    • Tsukahara, H.1    Gordienko, D.V.2    Tonshoff, B.3    Gelato, M.C.4    Goligorsky, M.S.5
  • 14
    • 0034714437 scopus 로고    scopus 로고
    • Insulin-like growth factor I retards apoptotic signaling induced by ethanol in cardiomyocytes
    • Chen DB, Wang L, Wang PH. Insulin-like growth factor I retards apoptotic signaling induced by ethanol in cardiomyocytes. Life Sci. 67(14), 1683-1693 (2000)
    • (2000) Life Sci. , vol.67 , Issue.14 , pp. 1683-1693
    • Chen, D.B.1    Wang, L.2    Wang, P.H.3
  • 15
    • 0033951649 scopus 로고    scopus 로고
    • The insulin-like growth factor axis: A review of atherosclerosis and restenosis
    • Bayes-Genis A, Conover CA, Schwartz RS. The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circ. Res. 86(2), 125-130 (2000) (Pubitemid 30086171)
    • (2000) Circulation Research , vol.86 , Issue.2 , pp. 125-130
    • Bayes-Genis, A.1    Conover, C.A.2    Schwartz, R.S.3
  • 17
    • 33745218966 scopus 로고    scopus 로고
    • Beginning to end: Cardiovascular implications of growth hormone GH deficiency and GH therapy
    • A
    • Colao A, Di Somma C, Savanelli MC, De Leo M, Lombardi G. Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy. Growth Horm. IGF Res. 16(Suppl. A), S41-S48 (2006)
    • (2006) Growth Horm. IGF Res. , vol.16
    • Colao, A.1    Di Somma, C.2    Savanelli, M.C.3    De Leo, M.4    Lombardi, G.5
  • 22
    • 0028843243 scopus 로고
    • Cardiac performance and mass in adults with hypopituitarism: Effects of one year of growth hormone treatment
    • Valcavi R, Gaddi O, Zini M et al. Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment. J. Clin. Endocrinol. Metab. 80(2), 659-666 (1995)
    • (1995) J. Clin. Endocrinol. Metab. , vol.80 , Issue.2 , pp. 659-666
    • Valcavi, R.1    Gaddi, O.2    Zini, M.3
  • 25
    • 2442526224 scopus 로고    scopus 로고
    • Impact of Growth Hormone (GH) Treatment on Cardiovascular Risk Factors in GH-Deficient Adults: A Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials
    • DOI 10.1210/jc.2003-030840
    • Maison P, Griffin S, Nicoue-Beglah M et al. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J. Clin. Endocrinol. Metab. 89(5), 2192-2199 (2004) (Pubitemid 38619852)
    • (2004) Journal of Clinical Endocrinology and Metabolism , vol.89 , Issue.5 , pp. 2192-2199
    • Maison, P.1    Griffin, S.2    Nicoue-Beglah, M.3    Haddad, N.4    Balkau, B.5    Chanson, P.6
  • 28
    • 0035726804 scopus 로고    scopus 로고
    • Commencing growth hormone replacement in adults with a fixed low dose. Effects on serum lipoproteins, glucose metabolism, body composition, and cardiovascular function
    • DOI 10.1054/ghir.2001.0240
    • Gillberg P, Bramnert M, Thoren M, Werner S, Johannsson G. Commencing growth hormone replacement in adults with a fixed low dose. Effects on serum lipoproteins, glucose metabolism, body composition, and cardiovascular function. Growth Horm IGF Res. 11(5), 273-281 (2001) (Pubitemid 34262639)
    • (2001) Growth Hormone and IGF Research , vol.11 , Issue.5 , pp. 273-281
    • Gillberg, P.1    Bramnert, M.2    Thoren, M.3    Werner, S.4    Johannsson, G.5
  • 30
    • 0028868301 scopus 로고
    • Effect of growth hormone hGH replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood
    • Nass R, Huber RM, Klauss V et al. Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. J. Clin. Endocrinol. Metab. 80(2), 552-557 (1995)
    • (1995) J. Clin. Endocrinol. Metab. , vol.80 , Issue.2 , pp. 552-557
    • Nass, R.1    Huber, R.M.2    Klauss, V.3
  • 32
    • 0034456111 scopus 로고    scopus 로고
    • The severity of chronic heart failure due to coronary artery disease predicts the endocrine effects of short-term growth hormone administration
    • DOI 10.1210/jc.85.4.1533
    • Osterziel KJ, Blum WF, Strohm O, Dietz R. The severity of chronic heart failure due to coronary artery disease predicts the endocrine effects of short-term growth hormone administration. J. Clin. Endocrinol. Metab. 85(4), 1533-1539 (2000) (Pubitemid 32289496)
    • (2000) Journal of Clinical Endocrinology and Metabolism , vol.85 , Issue.4 , pp. 1533-1539
    • Osterziel, K.J.1    Blum, W.F.2    Strohm, O.3    Dietz, R.4
  • 33
    • 77958604010 scopus 로고    scopus 로고
    • Insulin-like growth factor axis insulin-like growth factor-I/insulin-like growth factor-binding protein-3 as a prognostic predictor of heart failure: Association with adiponectin
    • Watanabe S, Tamura T, Ono K et al. Insulin-like growth factor axis (insulin-like growth factor-I/insulin-like growth factor-binding protein-3) as a prognostic predictor of heart failure: association with adiponectin. Eur. J. Heart Fail. 12(11), 1214-1222 (2010)
    • (2010) Eur. J. Heart Fail. , vol.12 , Issue.11 , pp. 1214-1222
    • Watanabe, S.1    Tamura, T.2    Ono, K.3
  • 35
    • 0029051227 scopus 로고
    • Growth hormone improves cardiac performance in experimental heart failure
    • Yang R, Bunting S, Gillett N, Clark R, Jin H. Growth hormone improves cardiac performance in experimental heart failure. Circulation 92(2), 262-267 (1995)
    • (1995) Circulation , vol.92 , Issue.2 , pp. 262-267
    • Yang, R.1    Bunting, S.2    Gillett, N.3    Clark, R.4    Jin, H.5
  • 36
    • 0029949746 scopus 로고    scopus 로고
    • Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat
    • Duerr RL, McKirnan MD, Gim RD et al. Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Circulation 93(12), 2188-2196 (1996) (Pubitemid 26187109)
    • (1996) Circulation , vol.93 , Issue.12 , pp. 2188-2196
    • Duerr, R.L.1    McKirnan, M.D.2    Gim, R.D.3    Clark, R.G.4    Chien, K.R.5    Ross Jr., J.6
  • 39
    • 0033547764 scopus 로고    scopus 로고
    • Recombinant growth hormone therapy in patients with ischemic cardiomyopathy: Effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity
    • Genth-Zotz S, Zotz R, Geil S et al. Recombinant growth hormone therapy in patients with ischemic cardiomyopathy: effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity. Circulation 99(1), 18-21 (1999) (Pubitemid 29035951)
    • (1999) Circulation , vol.99 , Issue.1 , pp. 18-21
    • Genth-Zotz, S.1    Zotz, R.2    Geil, S.3    Voigtlander, T.4    Meyer, J.5    Darius, H.6
  • 41
    • 0032994536 scopus 로고    scopus 로고
    • Growth hormone therapy in patients with dilated cardiomyopathy: Preliminary observations of a pilot study
    • Jose VJ, Zechariah TU, George P, Jonathan V. Growth hormone therapy in patients with dilated cardiomyopathy: preliminary observations of a pilot study. Indian Heart J. 51(2), 183-185 (1999) (Pubitemid 29288176)
    • (1999) Indian Heart Journal , vol.51 , Issue.2 , pp. 183-185
    • Jose, V.J.1    Zechariah, T.U.2    George, P.3    Jonathan, V.4
  • 45
    • 0037305044 scopus 로고    scopus 로고
    • Administration of growth hormone to patients with advanced cardiac heart failure: Effects upon left ventricular function, exercise capacity, and neurohormonal status
    • DOI 10.1016/S0167-5273(02)00249-8, PII S0167527302002498
    • Acevedo M, Corbalan R, Chamorro G et al. Administration of growth hormone to patients with advanced cardiac heart failure: effects upon left ventricular function, exercise capacity, and neurohormonal status. Int. J. Cardiol. 87(2-3), 185-191 (2003) (Pubitemid 36135975)
    • (2003) International Journal of Cardiology , vol.87 , Issue.2-3 , pp. 185-191
    • Acevedo, M.1    Corbalan, R.2    Chamorro, G.3    Jalil, J.4    Nazzal, C.5    Campusano, C.6    Castro, P.7
  • 46
    • 0033051329 scopus 로고    scopus 로고
    • Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness
    • DOI 10.1530/eje.0.1400017
    • Van den Berghe G, Wouters P, Bowers CY et al. Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness. Eur. J. Endocrinol. 140(1), 17-22 (1999) (Pubitemid 29074762)
    • (1999) European Journal of Endocrinology , vol.140 , Issue.1 , pp. 17-22
    • Van Den Berghe, G.1    Wouters, P.2    Bowers, C.Y.3    De Zegher, F.4    Bouillon, R.5    Veldhuis, J.D.6
  • 48
    • 40649119926 scopus 로고    scopus 로고
    • Growth hormone therapy in congestive heart failure due to left ventricular systolic dysfunction: A meta-analysis
    • Tritos NA, Danias PG. Growth hormone therapy in congestive heart failure due to left ventricular systolic dysfunction: a meta-analysis. Endocr. Pract. 14(1), 40-49 (2008)
    • (2008) Endocr. Pract. , vol.14 , Issue.1 , pp. 40-49
    • Tritos, N.A.1    Danias, P.G.2
  • 50
    • 0027501201 scopus 로고
    • Acquired growth hormone resistance in patients with hypercatabolism
    • Bentham J, Rodriguez-Arnao J, Ross RJ. Acquired growth hormone resistance in patients with hypercatabolism. Horm. Res. 40(1-3), 87-91 (1993) (Pubitemid 23349948)
    • (1993) Hormone Research , vol.40 , Issue.1-3 , pp. 87-91
    • Bentham, J.1    Rodriguez-Arnao, J.2    Ross, R.J.M.3
  • 51
    • 0029078053 scopus 로고
    • Acquired growth hormone resistance
    • Ross RJ, Chew SL. Acquired growth hormone resistance. Eur. J. Endocrinol. 132(6), 655-660 (1995)
    • (1995) Eur. J. Endocrinol. , vol.132 , Issue.6 , pp. 655-660
    • Ross, R.J.1    Chew, S.L.2
  • 52
    • 0000178621 scopus 로고    scopus 로고
    • Recombinant human growth hormone for aids-associated wasting
    • DOI 10.1345/aph.17255
    • Windisch PA, Papatheofanis FJ, Matuszewski KA. Recombinant human growth hormone for AIDS-associated wasting. Ann. Pharmacother. 32(4), 437-445 (1998) (Pubitemid 28166611)
    • (1998) Annals of Pharmacotherapy , vol.32 , Issue.4 , pp. 437-445
    • Windisch, P.A.1    Papatheofanis, F.J.2    Matuszewski, K.A.3
  • 53
  • 54
    • 0031565436 scopus 로고    scopus 로고
    • Treatment of end-state cardiac failure with growth hormone [2]
    • DOI 10.1016/S0140-6736(05)62290-8
    • O'Driscoll JG, Green DJ, Ireland M, Kerr D, Larbalestier RI. Treatment of end-stage cardiac failure with growth hormone. Lancet 349(9058), 1068 (1997) (Pubitemid 27158255)
    • (1997) Lancet , vol.349 , Issue.9058 , pp. 1068
    • O'Driscoll, J.G.1    Green, D.J.2    Ireland, M.3    Kerr, D.4    Larbalestier, R.I.5
  • 55
    • 0027533214 scopus 로고
    • Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously
    • Kupfer SR, Underwood LE, Baxter RC, Clemmons DR. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J. Clin. Invest. 91(2), 391-396 (1993) (Pubitemid 23064118)
    • (1993) Journal of Clinical Investigation , vol.91 , Issue.2 , pp. 391-396
    • Kupfer, S.R.1    Underwood, L.E.2    Baxter, R.C.3    Clemmons, D.R.4
  • 56
    • 33845503501 scopus 로고    scopus 로고
    • Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury
    • Hatton J, Kryscio R, Ryan M, Ott L, Young B. Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury. J. Neurosurg. 105(6), 843-852 (2006) (Pubitemid 44917386)
    • (2006) Journal of Neurosurgery , vol.105 , Issue.6 , pp. 843-852
    • Hatton, J.1    Kryscio, R.2    Ryan, M.3    Linda, O.4    Young, B.5
  • 58
    • 67349149713 scopus 로고    scopus 로고
    • Advantages and disadvantages of GH/IGF-I combination treatment
    • Janssen JA. Advantages and disadvantages of GH/IGF-I combination treatment. Rev. Endocr. Metab. Disord. 10(2), 157-162 (2009)
    • (2009) Rev. Endocr. Metab. Disord. , vol.10 , Issue.2 , pp. 157-162
    • Janssen, J.A.1
  • 59
    • 3042773859 scopus 로고    scopus 로고
    • Therapeutic applications of the insulin-like growth factors
    • DOI 10.1016/j.ghir.2004.04.001, PII S1096637404000735
    • Savage MO, Camacho-Hubner C, Dunger DB. Therapeutic applications of the insulin-like growth factors. Growth Horm. IGF Res. 14(4), 301-308 (2004). (Pubitemid 38878056)
    • (2004) Growth Hormone and IGF Research , vol.14 , Issue.4 , pp. 301-308
    • Savage, M.O.1    Camacho-Hubner, C.2    Dunger, D.B.3
  • 60
    • 0033023320 scopus 로고    scopus 로고
    • GH replacement in 1034 growth hormone deficient hypopituitary adults: Demographic and clinical characteristics, dosing and safety
    • DOI 10.1046/j.1365-2265.1999.00695.x
    • Abs R, Bengtsson BA, Hernberg-Stahl E et al. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clin. Endocrinol. (Oxf.) 50(6), 703-713 (1999) (Pubitemid 29284503)
    • (1999) Clinical Endocrinology , vol.50 , Issue.6 , pp. 703-713
    • Abs, R.1    Bengtsson, B.-A.2    Hernberg-Stahl, E.3    Monson, J.P.4    Tauber, J.-P.5    Wilton, P.6    Wuster, C.7
  • 61
    • 77949497802 scopus 로고    scopus 로고
    • Treatment of adult growth hormone deficiency: Who why and how a review
    • Alexopoulou O, Abs R, Maiter D. Treatment of adult growth hormone deficiency: who, why and how? A review. Acta Clin. Belg. 65(1), 13-22 (2010)
    • (2010) Acta Clin. Belg. , vol.65 , Issue.1 , pp. 13-22
    • Alexopoulou, O.1    Abs, R.2    Maiter, D.3
  • 62
    • 0028027050 scopus 로고
    • Potential for growth factor treatment of muscle disease
    • Moxley RT 3rd. Potential for growth factor treatment of muscle disease. Curr. Opin. Neurol. 7(5), 427-434 (1994) (Pubitemid 24282688)
    • (1994) Current Opinion in Neurology , vol.7 , Issue.5 , pp. 427-434
    • Moxley III, R.T.1
  • 64
    • 0033539123 scopus 로고    scopus 로고
    • Growth hormone therapy in critically ill patients
    • DOI 10.1056/NEJM199909093411110
    • Demling R. Growth hormone therapy in critically ill patients. N. Engl. J. Med. 341(11), 837-839 (1999) (Pubitemid 29420481)
    • (1999) New England Journal of Medicine , vol.341 , Issue.11 , pp. 837-839
    • Demling, R.1
  • 65
    • 0030724963 scopus 로고    scopus 로고
    • Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults
    • Johannsson G, Rosen T, Bengtsson BA. Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults. Clin. Endocrinol. (Oxf.) 47(5), 571-581 (1997) (Pubitemid 27496332)
    • (1997) Clinical Endocrinology , vol.47 , Issue.5 , pp. 571-581
    • Johannsson, G.1    Rosen, T.2    Bengtsson, B.-A.3
  • 70
    • 0025935923 scopus 로고
    • Domains of the human androgen receptor involved in steroid binding transcriptional activation and subcellular localization
    • Jenster G, van der Korput HA, van Vroonhoven C et al. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol. Endocrinol. 5(10), 1396-1404 (1991)
    • (1991) Mol. Endocrinol. , vol.5 , Issue.10 , pp. 1396-1404
    • Jenster, G.1    Van Der Korput, H.A.2    Van Vroonhoven, C.3
  • 72
    • 77956208593 scopus 로고    scopus 로고
    • Membrane testosterone receptors in cultured vascular smooth muscle cells
    • Ma R, Jiang SS, Cheng XM et al. [Membrane testosterone receptors in cultured vascular smooth muscle cells]. Zhonghua Nan Ke Xue 16(5), 428-432 (2010)
    • (2010) Zhonghua. Nan. Ke. Xue. , vol.16 , Issue.5 , pp. 428-432
    • Ma, R.1    Jiang, S.S.2    Cheng, X.M.3
  • 73
    • 0037349115 scopus 로고    scopus 로고
    • The vasodilatory action of testosterone: A potassium-channel opening or a calcium antagonistic action?
    • DOI 10.1038/sj.bjp.0705141
    • Jones RD, Pugh PJ, Jones TH, Channer KS. The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action? Br. J. Pharmacol. 138(5), 733-744 (2003) (Pubitemid 36390629)
    • (2003) British Journal of Pharmacology , vol.138 , Issue.5 , pp. 733-744
    • Jones, R.D.1    Pugh, P.J.2    Jones, T.H.3    Channer, K.S.4
  • 74
    • 4043174113 scopus 로고    scopus 로고
    • Testosterone-induced coronary vasodilatation occurs via a non-genomic mechanism: Evidence of a direct calcium antagonism action
    • DOI 10.1042/CS20030386
    • Jones RD, English KM, Jones TH, Channer KS. Testosterone-induced coronary vasodilatation occurs via a non-genomic mechanism: evidence of a direct calcium antagonism action. Clin. Sci. (Lond.) 107(2), 149-158 (2004) (Pubitemid 39070931)
    • (2004) Clinical Science , vol.107 , Issue.2 , pp. 149-158
    • Jones, R.D.1    English, K.M.2    Hugh Jones, T.3    Channer, K.S.4
  • 75
    • 0037991446 scopus 로고    scopus 로고
    • Acute haemodynamic effects of testosterone in men with chronic heart failure
    • DOI 10.1016/S0195-668X(03)00083-6
    • Pugh PJ, Jones TH, Channer KS. Acute haemodynamic effects of testosterone in men with chronic heart failure. Eur. Heart J. 24(10), 909-915 (2003) (Pubitemid 36559984)
    • (2003) European Heart Journal , vol.24 , Issue.10 , pp. 909-915
    • Pugh, P.J.1    Jones, T.H.2    Channer, K.S.3
  • 76
    • 35848940534 scopus 로고    scopus 로고
    • Effects of testosterone on cytokines and left ventricular remodeling following heart failure
    • DOI 10.1159/000110444
    • Zhang YZ, Xing XW, He B, Wang LX. Effects of testosterone on cytokines and left ventricular remodeling following heart failure. Cell Physiol. Biochem. 20(6), 847-852 (2007) (Pubitemid 350059727)
    • (2007) Cellular Physiology and Biochemistry , vol.20 , Issue.6 , pp. 847-852
    • Zhang, Y.-Z.1    Xing, X.-W.2    He, B.3    Wang, L.-X.4
  • 77
    • 77951928138 scopus 로고    scopus 로고
    • Testosterone therapy improves cardiac function of male rats with right heart failure
    • Li ZB, Wang J, Wang JX, Chen XM, Jiang SS. [Testosterone therapy improves cardiac function of male rats with right heart failure]. Zhonghua Nan Ke Xue 15(11), 994-1000 (2009)
    • (2009) Zhonghua. Nan. Ke. Xue. , vol.15 , Issue.11 , pp. 994-1000
    • Li, Z.B.1    Wang, J.2    Wang, J.X.3    Chen, X.M.4    Jiang, S.S.5
  • 79
    • 68849113580 scopus 로고    scopus 로고
    • Neuroendocrine effects on the heart and targets for therapeutic manipulation in heart failure
    • Chaggar PS, Malkin CJ, Shaw SM, Williams SG, Channer KS. Neuroendocrine effects on the heart and targets for therapeutic manipulation in heart failure. Cardiovasc. Ther. 27(3), 187-193 (2009)
    • (2009) Cardiovasc. Ther. , vol.27 , Issue.3 , pp. 187-193
    • Chaggar, P.S.1    Malkin, C.J.2    Shaw, S.M.3    Williams, S.G.4    Channer, K.S.5
  • 80
    • 77950551563 scopus 로고    scopus 로고
    • Low circulating androgens and mortality risk in heart failure
    • Guder G, Frantz S, Bauersachs J et al. Low circulating androgens and mortality risk in heart failure. Heart 96(7), 504-509 (2010)
    • (2010) Heart , vol.96 , Issue.7 , pp. 504-509
    • Guder, G.1    Frantz, S.2    Bauersachs, J.3
  • 81
    • 28944442442 scopus 로고    scopus 로고
    • Testosterone therapy in men with moderate severity heart failure: A double-blind randomized placebo controlled trial
    • DOI 10.1093/eurheartj/ehi443
    • Malkin CJ, Pugh PJ, West JN et al. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. Eur. Heart J. 27(1), 57-64 (2006) (Pubitemid 41785933)
    • (2006) European Heart Journal , vol.27 , Issue.1 , pp. 57-64
    • Malkin, C.J.1    Pugh, P.J.2    West, J.N.3    Van Beek, E.J.R.4    Jones, T.H.5    Channer, K.S.6
  • 82
    • 0032948205 scopus 로고    scopus 로고
    • Effect of oxymetholone on left ventricular dimensions in heart failure secondary to idiopathic dilated cardiomyopathy or to mitral or aortic regurgitation
    • DOI 10.1016/S0002-9149(98)00796-6, PII S0002914998007966
    • Tomoda H. Effect of oxymetholone on left ventricular dimensions in heart failure secondary to idiopathic dilated cardiomyopathy or to mitral or aortic regurgitation. Am. J. Cardiol. 83(1), 123-125, A9 (1999) (Pubitemid 29036661)
    • (1999) American Journal of Cardiology , vol.83 , Issue.1 , pp. 123-125
    • Tomoda, H.1
  • 83
    • 68949172537 scopus 로고    scopus 로고
    • Effect of long-acting testosterone treatment on functional exercise capacity skeletal muscle performance insulin resistance and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind placebo-controlled randomized study
    • Caminiti G, Volterrani M, Iellamo F et al. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J. Am. Coll. Cardiol. 54(10), 919-927 (2009)
    • (2009) J. Am. Coll. Cardiol. , vol.54 , Issue.10 , pp. 919-927
    • Caminiti, G.1    Volterrani, M.2    Iellamo, F.3
  • 84
    • 77957334994 scopus 로고    scopus 로고
    • Testosterone therapy in women with chronic heart failure: A pilot double-blind randomized placebo-controlled study
    • Iellamo F, Volterrani M, Caminiti G et al. Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. J. Am. Coll. Cardiol. 56(16), 1310-1316 (2010)
    • (2010) J. Am. Coll. Cardiol. , vol.56 , Issue.16 , pp. 1310-1316
    • Iellamo, F.1    Volterrani, M.2    Caminiti, G.3
  • 85
    • 34248563042 scopus 로고    scopus 로고
    • Testosterone replacement therapy and prostate cancer: A word of caution
    • DOI 10.1007/s11934-007-0004-x
    • Brand TC, Canby-Hagino E, Thompson IM. Testosterone replacement therapy and prostate cancer: a word of caution. Curr. Urol. Rep. 8(3), 185-189 (2007) (Pubitemid 46806646)
    • (2007) Current Urology Reports , vol.8 , Issue.3 , pp. 185-189
    • Brand, T.C.1    Canby-Hagino, E.2    Thompson, I.M.3
  • 86
    • 0037241928 scopus 로고    scopus 로고
    • Testosterone supplementation therapy for older men: Potential benefits and risks
    • DOI 10.1034/j.1601-5215.2002.51018.x
    • Gruenewald DA, Matsumoto AM. Testosterone supplementation therapy for older men: potential benefits and risks. J. Am. Geriatr. Soc. 51(1), 101-115; discussion 115 (2003) (Pubitemid 36119943)
    • (2003) Journal of the American Geriatrics Society , vol.51 , Issue.1 , pp. 101-115
    • Gruenewald, D.A.1    Matsumoto, A.M.2
  • 88
    • 1642463867 scopus 로고    scopus 로고
    • Testosterone treatment for men with chronic heart failure
    • Pugh PJ, Jones RD, West JN, Jones TH, Channer KS. Testosterone treatment for men with chronic heart failure. Heart 90(4), 446-447 (2004) (Pubitemid 38406925)
    • (2004) Heart , vol.90 , Issue.4 , pp. 446-447
    • Pugh, P.J.1    Jones, R.D.2    West, J.N.3    Jones, T.H.4    Channer, K.S.5
  • 89
    • 77954409942 scopus 로고    scopus 로고
    • Testosterone therapy in men with androgen deficiency syndromes: An endocrine Society clinical practice guideline
    • Bhasin S, Cunningham GR, Hayes FJ et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 95(6), 2536-2559 (2010)
    • (2010) J. Clin. Endocrinol. Metab. , vol.95 , Issue.6 , pp. 2536-2559
    • Bhasin, S.1    Cunningham, G.R.2    Hayes, F.J.3
  • 90
    • 77954421915 scopus 로고    scopus 로고
    • Adverse events associated with testosterone administration
    • Basaria S, Coviello AD, Travison TG et al. Adverse events associated with testosterone administration. N. Engl. J. Med. 363(2), 109-122 (2010)
    • (2010) N. Engl. J. Med. , vol.363 , Issue.2 , pp. 109-122
    • Basaria, S.1    Coviello, A.D.2    Travison, T.G.3
  • 91
    • 0026593243 scopus 로고
    • Serum cholesterol blood pressure cigarette smoking and death from coronary heart disease overall findings and differences by age for 316099 white men
    • Multiple Risk Factor Intervention Trial Research Group
    • Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch. Intern. Med. 152(1), 56-64 (1992)
    • (1992) Arch. Intern. Med. , vol.152 , Issue.1 , pp. 56-64
    • Neaton, J.D.1    Wentworth, D.2
  • 92
    • 66749140429 scopus 로고    scopus 로고
    • Testosterone and growth hormone improve body composition and muscle performance in older men
    • Sattler FR, Castaneda-Sceppa C, Binder EF et al. Testosterone and growth hormone improve body composition and muscle performance in older men. J. Clin. Endocrinol. Metab. 94(6), 1991-2001 (2009)
    • (2009) J. Clin. Endocrinol. Metab. , vol.94 , Issue.6 , pp. 1991-2001
    • Sattler, F.R.1    Castaneda-Sceppa, C.2    Binder, E.F.3
  • 93
    • 0036924729 scopus 로고    scopus 로고
    • Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men
    • DOI 10.1210/jc.2002-020098
    • Brill KT, Weltman AL, Gentili A et al. Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men. J. Clin. Endocrinol. Metab. 87(12), 5649-5657 (2002). (Pubitemid 36034373)
    • (2002) Journal of Clinical Endocrinology and Metabolism , vol.87 , Issue.12 , pp. 5649-5657
    • Brill, K.T.1    Weltman, A.L.2    Gentili, A.3    Patrie, J.T.4    Fryburg, D.A.5    Hanks, J.B.6    Urban, R.J.7    Veldhuis, J.D.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.